Neurological Complications of Herpes Zoster - a Case Report

被引:0
作者
Chlibek, R. [1 ]
Smetana, J. [1 ]
Bastikova, V. [1 ]
Kosina, P. [2 ]
Prasil, P. [2 ]
Salavec, M. [3 ]
Rejtar, P. [4 ]
Bostik, P. [5 ]
机构
[1] Fak Vojenskeho Zdravotnictvi UO, Katedra Epidemiol, Hradec Kralove 50001, Czech Republic
[2] LF UK & FN Hradec Kralove, Klin Infekcnich Nemoci, Hradec Kralove, Czech Republic
[3] LF UK & FN Hradec Kralove, Katedra Dermatovenerol, Hradec Kralove, Czech Republic
[4] LF UK & FN Hradec Kralove, Radiol Klin, Hradec Kralove, Czech Republic
[5] Univ Obrany, Fak Vojenskeho Zdravotnictvi, Ctr Pokrocilych Studii, Hradec Kralove, Czech Republic
关键词
herpes zoster; neurological complications; varicella-zoster virus; epidemiology; POSTHERPETIC NEURALGIA; EPIDEMIOLOGY; SHINGLES;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Herpes zoster (HZ) is not a rare disease the average annual incidence in Czech Republic only was 6,306 cases (61,3 per 100 thousand inhabitants) during the period 1990-2008. The peak incidence age group is between 60-70 years, however the risk for the disease increases steadily after 50 years of age and so does the likelihood for the development of complications.The most common complications reported in Czech Republic during the year 2008 were those affecting central nervous system (CNS), such as meningitis, encephalitis and other diseases of CNS (30, 21 and 20 cases, respectively), followed by ocular involvement (94 cases) and generalized herpes zoster (13 cases). Immunosuppression increases the risk of the development of disease, the severity of attack and the likelihood of complications. Here we present a case report of herpes zoster in a patient with several co-morbidities, who developed neurological complications.The case report contains a review of basic epidemiological and clinical characteristics of HZ, as well as common complications of this disease, and a summary of the epidemiological situation in Czech Republic.
引用
收藏
页码:486 / 489
页数:4
相关论文
共 11 条
[1]   The incidence of shingles and its implications for vaccination policy [J].
Chapman, RS ;
Cross, KW ;
Fleming, DM .
VACCINE, 2003, 21 (19-20) :2541-2547
[2]   The epidemiology of Varicella Zoster Virus infection in Italy [J].
Gabutti, Giovanni ;
Rota, Maria C. ;
Guido, Marcello ;
De Donno, Antonella ;
Bella, Antonino ;
degli Atti, Marta L. Ciofi ;
Crovari, Pietro .
BMC PUBLIC HEALTH, 2008, 8 (1)
[3]   Management of herpes zoster (shingles) and postherpetic neuralgia [J].
Johnson, RW ;
Whitton, TL .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) :551-559
[4]   Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: Evidence for high conservation of circulating genotypes [J].
Loparev, Vladimir N. ;
Rubtcova, Elena N. ;
Bostik, Vanda ;
Tzaneva, Valentina ;
Sauerbrei, Andreas ;
Robo, Alma ;
Sattler-Dornbacher, Eva ;
Hanovcova, Iva ;
Stepanova, Vera ;
Splino, Miroslav ;
Eremin, Vladimir ;
Koskiniemi, Marjaleena ;
Vankova, Olga E. ;
Schmid, D. Scott .
VIROLOGY, 2009, 383 (02) :216-225
[5]   Gender as an independent risk factor for herpes zoster: A population-based prospective study [J].
Opstelten, Wim ;
Van Essen, Gerrit A. ;
Schellevis, Francois ;
Verheij, Theo J. M. ;
Moons, Karel G. M. .
ANNALS OF EPIDEMIOLOGY, 2006, 16 (09) :692-695
[6]  
Roubalova K., 1998, ZPRAVY CEM, V7, P29
[7]   Herpes Zoster (Shingles) and Postherpetic Neuralgia [J].
Sampathkumar, Priya ;
Drage, Lisa A. ;
Martin, David P. .
MAYO CLINIC PROCEEDINGS, 2009, 84 (03) :274-280
[8]   Zoster Vaccine (Zostavax®) A Review of its Use in Preventing Herpes Zoster and Postherpetic Neuralgia in Older Adults [J].
Sanford, Mark ;
Keating, Gillian M. .
DRUGS & AGING, 2010, 27 (02) :159-176
[9]   What does epidemiology tell us about risk factors for herpes zoster? [J].
Thomas, SL ;
Hall, AJ .
LANCET INFECTIOUS DISEASES, 2004, 4 (01) :26-33
[10]   Herpes zoster: Epidemiology, natural history, and common complications [J].
Weinberg, Jeffrey M. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (06) :S130-S135